Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Sexual well-being after menopause: An International Menopause Society White Paper.

Simon JA, Davis SR, Althof SE, Chedraui P, Clayton AH, Kingsberg SA, Nappi RE, Parish SJ, Wolfman W.

Climacteric. 2018 Jul 10:1-13. doi: 10.1080/13697137.2018.1482647. [Epub ahead of print]

PMID:
29987939
2.

The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.

Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Lowenstein L, Pinkerton JV, Stuenkel CA, Traish AM, Archer DF, Bachmann G, Goldstein AT, Nappi RE, Vignozzi L.

Menopause. 2018 Jul;25(7):837-847. doi: 10.1097/GME.0000000000001138.

PMID:
29870471
3.

Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America.

Nappi RE, de Melo NR, Martino M, Celis-González C, Villaseca P, Röhrich S, Palacios S.

Climacteric. 2018 Aug;21(4):397-403. doi: 10.1080/13697137.2018.1461826. Epub 2018 May 9.

PMID:
29741110
4.

The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause.

Palacios S, Nappi RE, Bruyniks N, Particco M, Panay N; EVES Study Investigators.

Climacteric. 2018 Jun;21(3):286-291. doi: 10.1080/13697137.2018.1446930. Epub 2018 Mar 19.

PMID:
29553288
5.

Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment.

Parish SJ, Nappi RE, Kingsberg S.

Menopause. 2018 Mar 5. doi: 10.1097/GME.0000000000001088. [Epub ahead of print]

PMID:
29509600
6.

Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?

Nappi RE, Cucinella L, Tiranini L, Martini E.

Expert Opin Pharmacother. 2018 Apr;19(5):421-423. doi: 10.1080/14656566.2018.1444751. Epub 2018 Feb 28. No abstract available.

PMID:
29488405
7.

Couplepause: A New Paradigm in Treating Sexual Dysfunction During Menopause and Andropause.

Jannini EA, Nappi RE.

Sex Med Rev. 2018 Jul;6(3):384-395. doi: 10.1016/j.sxmr.2017.11.002. Epub 2018 Jan 19. Review.

PMID:
29371146
8.

Male perception about the inconveniences associated with monthly bleeding for their partner - an international survey.

Lete I, Lobo P, Nappi RE, Pintiaux A, Fiala C, Häusler G, Chabbert-Buffet N.

Eur J Contracept Reprod Health Care. 2018 Feb;23(1):1-11. doi: 10.1080/13625187.2017.1423284. Epub 2018 Jan 22.

PMID:
29355396
9.

Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey.

Nappi RE, Lete I, Lee LK, Flores NM, Micheletti MC, Tang B.

BMC Womens Health. 2018 Jan 18;18(1):22. doi: 10.1186/s12905-017-0508-6.

10.

Efficacy and tolerability of a spray formulation containing Visnadine in women self-reporting sexual symptoms: a randomized double-blind placebo-controlled pilot study.

Bernorio R, Piloni S, Mori G, Prunas A, Bosoni D, Nappi RE.

J Endocrinol Invest. 2018 Jun;41(6):729-737. doi: 10.1007/s40618-017-0801-0. Epub 2017 Dec 11.

PMID:
29230716
11.

Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14.

Kingsberg SA, Althof S, Simon JA, Bradford A, Bitzer J, Carvalho J, Flynn KE, Nappi RE, Reese JB, Rezaee RL, Schover L, Shifrin JL.

J Sex Med. 2017 Dec;14(12):1463-1491. doi: 10.1016/j.jsxm.2017.05.018. Review. Erratum in: J Sex Med. 2018 Feb;15(2):270.

PMID:
29198504
12.

The inconvenience due to women's monthly bleeding (ISY) survey: a study of premenstrual symptoms among 5728 women in Europe.

Lete I, Häusler G, Pintiaux A, Jamin C, Nappi RE, Fiala C, Chabbert-Buffet N, Lobo P.

Eur J Contracept Reprod Health Care. 2017 Oct;22(5):354-359. doi: 10.1080/13625187.2017.1400001. Epub 2017 Nov 20.

PMID:
29157023
13.

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).

Sacco S, Merki-Feld GS, Ægidius KL, Bitzer J, Canonico M, Kurth T, Lampl C, Lidegaard Ø, Anne MacGregor E, MaassenVanDenBrink A, Mitsikostas DD, Nappi RE, Ntaios G, Sandset PM, Martelletti P; European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).

J Headache Pain. 2017 Oct 30;18(1):108. doi: 10.1186/s10194-017-0815-1.

14.
15.

Development and conceptual validation of a questionnaire to help contraceptive choice: CHLOE (Contraception: HeLping for wOmen's choicE).

Jamin CG, Häusler G, Lobo Abascal P, Fiala C, Lete Lasa LI, Nappi RE, Micheletti MC, Fernández-Dorado A, Pintiaux A, Chabbert-Buffet N.

Eur J Contracept Reprod Health Care. 2017 Aug;22(4):286-290. doi: 10.1080/13625187.2017.1364719. Epub 2017 Sep 7.

PMID:
28877640
16.

Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women.

Nappi RE, Cagnacci A, Becorpi AM, Nappi C, Paoletti AM, Busacca M, Martella S, Bellafronte M, Tredici Z, Di Carlo C, Corda V, Vignali M, Bagolan M, Sardina M.

Climacteric. 2017 Oct;20(5):467-475. doi: 10.1080/13697137.2017.1335703. Epub 2017 Jun 28.

PMID:
28657769
17.

Women's preferences for menstrual bleeding frequency in 12 European countries: the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.

Fiala C, Chabbert-Buffet N, Häusler G, Jamin C, Lete I, Lobo P, Nappi RE, Pintiaux A.

Eur J Contracept Reprod Health Care. 2017 Aug;22(4):268-273. doi: 10.1080/13625187.2017.1334258. Epub 2017 Jun 26.

PMID:
28650776
18.

Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?

Biglia N, Cagnacci A, Gambacciani M, Lello S, Maffei S, Nappi RE.

Climacteric. 2017 Aug;20(4):306-312. doi: 10.1080/13697137.2017.1315089. Epub 2017 Apr 28. Review.

19.

Clinical profile of women with vulvar and vaginal atrophy who are not candidates for local vaginal estrogen therapy.

Nappi RE, Murina F, Perrone G, Villa P, Biglia N.

Minerva Ginecol. 2017 Aug;69(4):370-380. doi: 10.23736/S0026-4784.17.04064-3. Epub 2017 Apr 10. Review.

20.

Missed pills: frequency, reasons, consequences and solutions.

Chabbert-Buffet N, Jamin C, Lete I, Lobo P, Nappi RE, Pintiaux A, Häusler G, Fiala C.

Eur J Contracept Reprod Health Care. 2017 Jun;22(3):165-169. doi: 10.1080/13625187.2017.1295437. Epub 2017 Mar 9. Review.

PMID:
28277799
21.

Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data.

Nappi RE, Particco M, Biglia N, Cagnacci A, Di Carlo C, Luisi S, Paoletti AM.

Gynecol Endocrinol. 2017 May;33(5):389-394. doi: 10.1080/09513590.2017.1284783. Epub 2017 Feb 21.

22.

CLarifying vaginal atrophy's impact On SEx and Relationships (CLOSER) survey in South Africa.

Guidozzi F, Thomas C, Smith T, Nappi RE.

Climacteric. 2017 Feb;20(1):49-54. doi: 10.1080/13697137.2016.1262838. Epub 2017 Jan 2.

PMID:
28042713
23.

The sexuological impact of hormonal contraceptives based on their route of administration.

Guida M, Di Carlo C, Troisi J, Gallo A, Cibarelli F, Martini E, Tiranini L, Nappi RE.

Gynecol Endocrinol. 2017 Mar;33(3):218-222. doi: 10.1080/09513590.2016.1249841. Epub 2016 Dec 2.

PMID:
27908210
24.

Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL).

Nappi RE, Cucinella L, Martella S, Rossi M, Tiranini L, Martini E.

Maturitas. 2016 Dec;94:87-91. doi: 10.1016/j.maturitas.2016.09.013. Epub 2016 Sep 28. Review.

PMID:
27823751
25.

The role of gender, psycho-social factors and anthropological-cultural dimensions on pain in neurorehabilitation. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Aloisi AM, Berlincioni V, Torta R, Nappi RE, Tassorelli C, Barale F, Ieraci V, Giusti EM, Pietrabissa G, Tamburin S, Manzoni GM, Castelnuovo G; Italian Consensus Conference on Pain in Neurorehabilitation (ICCPN).

Eur J Phys Rehabil Med. 2016 Oct;52(5):730-740. Epub 2016 Sep 16. Review.

26.

Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study.

De Icco R, Cucinella L, De Paoli I, Martella S, Sances G, Bitetto V, Sandrini G, Nappi G, Tassorelli C, Nappi RE.

J Headache Pain. 2016 Dec;17(1):70. doi: 10.1186/s10194-016-0661-6. Epub 2016 Aug 4.

27.

The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs.

Nappi RE, Palacios S, Particco M, Panay N.

Maturitas. 2016 Sep;91:81-90. doi: 10.1016/j.maturitas.2016.06.010. Epub 2016 Jun 15.

PMID:
27451325
28.

Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey.

Nappi RE, Particco M, Biglia N, Cagnacci A, Di Carlo C, Luisi S, Paoletti AM.

Maturitas. 2016 Sep;91:74-80. doi: 10.1016/j.maturitas.2016.06.009. Epub 2016 Jun 11.

29.

Efficacy, tolerability and safety of a new medical device, Monurelle Biogel(®) vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of reproductive age.

Nappi RE, Benedetto C, Campolo F, Martella S, Tosti C, Cianci A, Caruso S, Guaschino S, Grimaldi E, Bagolan M, Sardina M.

Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:82-8. doi: 10.1016/j.ejogrb.2016.05.005. Epub 2016 May 26.

PMID:
27261817
30.

Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group.

Nappi RE, Biglia N, Cagnacci A, Di Carlo C, Luisi S, Paoletti AM.

Gynecol Endocrinol. 2016 Aug;32(8):602-606. Epub 2016 May 17. Review.

31.

The American-European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE Survey.

Nappi RE, Krychman ML.

Climacteric. 2016 Jun;19(3):252-5. doi: 10.3109/13697137.2016.1173026. Epub 2016 Apr 20.

PMID:
27094975
32.

Women's preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.

Nappi RE, Fiala C, Chabbert-Buffet N, Häusler G, Jamin C, Lete I, Lukasiewic M, Pintiaux A, Lobo P.

Eur J Contracept Reprod Health Care. 2016 Jun;21(3):242-50. doi: 10.3109/13625187.2016.1154144. Epub 2016 Mar 24.

PMID:
27010535
33.

Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer.

Nappi RE, Cassani C, Rossi M, Zanellini F, Spinillo A.

Minerva Ginecol. 2016 Oct;68(5):602-12. Epub 2016 Feb 29. Review.

PMID:
26928421
34.

Sexual dysfunction in 2015: Recovering sex drive in women - progress and opportunities.

Nappi RE, Albani F.

Nat Rev Urol. 2016 Feb;13(2):67-8. doi: 10.1038/nrurol.2015.314. Epub 2016 Jan 12. No abstract available.

PMID:
26754192
35.

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy.

Bruyniks N, Nappi RE, Castelo-Branco C, de Villiers TJ, Simon J.

Climacteric. 2016;19(1):60-5. doi: 10.3109/13697137.2015.1113517. Epub 2015 Nov 19.

36.

Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.

Nappi RE, Palacios S, Panay N, Particco M, Krychman ML.

Climacteric. 2016 Apr;19(2):188-97. doi: 10.3109/13697137.2015.1107039. Epub 2015 Nov 19. Erratum in: Climacteric. 2016 Apr;19(2):i.

37.

Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.

Nappi RE, Kaunitz AM, Bitzer J.

Eur J Contracept Reprod Health Care. 2016;21(2):106-15. doi: 10.3109/13625187.2015.1107894. Epub 2015 Nov 17. Review.

38.

Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.

Magri F, Schena L, Capelli V, Gaiti M, Zerbini F, Brambilla E, Rotondi M, De Amici M, Spinillo A, Nappi RE, Chiovato L.

Reprod Biol Endocrinol. 2015 Sep 21;13(1):106. doi: 10.1186/s12958-015-0103-3.

39.

Effect of local estrogen therapy (LET) on urinary and sexual symptoms in premenopausal women with interstitial cystitis/bladder pain syndrome (IC/BPS).

Gardella B, Iacobone AD, Porru D, Musacchi V, Dominoni M, Tinelli C, Spinillo A, Nappi RE.

Gynecol Endocrinol. 2015 Oct;31(10):828-32. doi: 10.3109/09513590.2015.1063119. Epub 2015 Jul 31.

PMID:
26291799
40.

Update on management of genitourinary syndrome of menopause: A practical guide.

Palacios S, Castelo-Branco C, Currie H, Mijatovic V, Nappi RE, Simon J, Rees M.

Maturitas. 2015 Nov;82(3):308-13. doi: 10.1016/j.maturitas.2015.07.020. Epub 2015 Jul 26. Review.

PMID:
26261035
41.

Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?

Biglia N, Bounous VE, Sgro LG, D'Alonzo M, Pecchio S, Nappi RE.

Clin Breast Cancer. 2015 Dec;15(6):413-20. doi: 10.1016/j.clbc.2015.06.005. Epub 2015 Jun 18. Review.

PMID:
26198332
42.

To be or not to be in sexual desire: the androgen dilemma.

Nappi RE.

Climacteric. 2015 Oct;18(5):672-4. doi: 10.3109/13697137.2015.1064268.

PMID:
26176767
43.

Why are there no FDA-approved treatments for female sexual dysfunction?

Nappi RE.

Expert Opin Pharmacother. 2015;16(12):1735-8. doi: 10.1517/14656566.2015.1064393. Epub 2015 Jul 13.

PMID:
26165387
44.

Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection.

Castelo-Branco C, Biglia N, Nappi RE, Schwenkhagen A, Palacios S.

Maturitas. 2015 Aug;81(4):462-9. doi: 10.1016/j.maturitas.2015.05.007. Epub 2015 May 30.

45.

Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.

Lete I, Chabbert-Buffet N, Jamin C, Lello S, Lobo P, Nappi RE, Pintiaux A.

Eur J Contracept Reprod Health Care. 2015;20(5):329-43. doi: 10.3109/13625187.2015.1050091. Epub 2015 May 26. Review.

PMID:
26007631
46.

Diurnal Variation of Plasma Brain-Derived Neurotrophic Factor Levels in Women with Functional Hypothalamic Amenorrhea.

Drakopoulos P, Casarosa E, Bucci F, Piccinino M, Wenger JM, Nappi RE, Polyzos N, Genazzani AR, Pluchino N.

Neuroendocrinology. 2015;101(3):256-62. doi: 10.1159/000381456. Epub 2015 Mar 13.

PMID:
25791538
47.

Advances in pharmacotherapy for treating female sexual dysfunction.

Nappi RE, Cucinella L.

Expert Opin Pharmacother. 2015 Apr;16(6):875-87. doi: 10.1517/14656566.2015.1020791. Epub 2015 Mar 2. Review.

PMID:
25732267
48.

Endometriosis and perceived stress: impact of surgical and medical treatment.

Lazzeri L, Orlandini C, Vannuccini S, Pinzauti S, Tosti C, Zupi E, Nappi RE, Petraglia F.

Gynecol Obstet Invest. 2015;79(4):229-33. doi: 10.1159/000368776. Epub 2015 Jan 14.

PMID:
25591624
49.

Surgical treatment affects perceived stress differently in women with endometriosis: correlation with severity of pain.

Lazzeri L, Vannuccini S, Orlandini C, Luisi S, Zupi E, Nappi RE, Petraglia F.

Fertil Steril. 2015 Feb;103(2):433-8. doi: 10.1016/j.fertnstert.2014.10.036. Epub 2014 Dec 6.

PMID:
25487748
50.

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy.

Nappi RE, Panay N, Bruyniks N, Castelo-Branco C, De Villiers TJ, Simon JA.

Climacteric. 2015 Apr;18(2):233-40. doi: 10.3109/13697137.2014.975199. Epub 2014 Dec 16.

Supplemental Content

Loading ...
Support Center